These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10739397)

  • 1. Effect of instruments on lupus anticoagulant testing.
    Exner T; Hohnen-Behrens C; Newman P; Dargan W
    Thromb Haemost; 2000 Feb; 83(2):345-8. PubMed ID: 10739397
    [No Abstract]   [Full Text] [Related]  

  • 2. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers.
    Lawrie AS; Mackie IJ; Purdy G; Machin SJ
    Thromb Haemost; 1999 May; 81(5):758-62. PubMed ID: 10365750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated partial thromboplastin time reagents: an evaluation.
    Howarth S
    Br J Biomed Sci; 1993 Jun; 50(2):109-13. PubMed ID: 8219915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupus anticoagulant testing: effect of the platelet count on the activated partial thromboplastin time.
    Brien WF; Schaus MR; Cooper KE; O'Keefe BT; Inwood M
    Br J Biomed Sci; 1993 Jun; 50(2):114-6. PubMed ID: 8219916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated partial thromboplastin time for automated techniques: a comparison of two commonly used reagents.
    Craig S; Stevenson KJ; Taberner DA
    Br J Biomed Sci; 1994 Dec; 51(4):321-7. PubMed ID: 7756937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivaroxaban and false positive lupus anticoagulant testing.
    Merriman E; Kaplan Z; Butler J; Malan E; Gan E; Tran H
    Thromb Haemost; 2011 Feb; 105(2):385-6. PubMed ID: 21103666
    [No Abstract]   [Full Text] [Related]  

  • 7. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of subcutaneous administration of dalteparin on lupus anticoagulant assays.
    Liestøl S; Wisløff F
    Thromb Res; 2005; 115(6):509-17. PubMed ID: 15792683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantitative evaluation of lupus circulating anticoagulant activity.
    Rosner E; Pauzner R; Lusky A; Modan M; Many A
    Thromb Haemost; 1987 Apr; 57(2):144-7. PubMed ID: 3110995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged activated partial thromboplastin times and detection of the lupus anticoagulant.
    Lucas FV; Miller ML
    Arch Pathol Lab Med; 1993 Jun; 117(6):589-90. PubMed ID: 8503727
    [No Abstract]   [Full Text] [Related]  

  • 11. A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests.
    Zhang L; Whitis JG; Embry MB; Hollensead SC
    Am J Clin Pathol; 2005 Dec; 124(6):894-901. PubMed ID: 16416739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Activated Seven Lupus Anticoagulant (ASLA) test has comparable sensitivity to classical assays for screening of lupus anticoagulant.
    Marinuzzo M; Adamczuk Y; Varela ML; Pombo G; Forastiero R
    Thromb Haemost; 2005 May; 93(5):1007-9. PubMed ID: 15900652
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of a modified procedure for Staclot LA for the confirmation of lupus anticoagulants.
    Charles LA; McGlasson DL; Hawksworth BA; Ashcraft JH; Ortel TL
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):601-4. PubMed ID: 7841317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of sensitivity and specificity of a standardized procedure using different reagents for the detection of lupus anticoagulants. The Working Group on Hemostasis of the Société Française de Biologie Clinique and for the Groupe d'Etudes sur I'Hémostase et la Thrombose.
    Goudemand J; Caron C; De Prost D; Derlon A; Borg JY; Sampol J; Sié P
    Thromb Haemost; 1997 Feb; 77(2):336-42. PubMed ID: 9157593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preparation of a sensitive partial thromboplastin reagent from bovine brain.
    Martin BA; Branch DW; Rodgers GM
    Blood Coagul Fibrinolysis; 1992 Jun; 3(3):287-94. PubMed ID: 1643206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance.
    Ragland BD; Reed CE; Eiland BM; Tichenor PH; Hudson CL; Fritsma GA; Adler BK; Marques MB
    Am J Clin Pathol; 2003 Jan; 119(1):66-71. PubMed ID: 12520699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5.
    Jacobsen EM; Barna-Cler L; Taylor JM; Triplett DA; Wisløff F
    Thromb Haemost; 2000 May; 83(5):704-8. PubMed ID: 10823266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False positive lupus anticoagulant tests in patients with high C-reactive protein: A comparison of two hexagonal phase reagents.
    Mize R; Mueller S; Roth M; Montgomery G; Battinelli EM; Uljon S
    Int J Lab Hematol; 2024 Apr; 46(2):411-414. PubMed ID: 38185483
    [No Abstract]   [Full Text] [Related]  

  • 19. Conceptions and misconceptions in testing for lupus anticoagulants.
    Exner T
    J Autoimmun; 2000 Sep; 15(2):179-83. PubMed ID: 10968906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring the effect of heparin bolus during percutaneous coronary angioplasty (PTCA): assessment of three bedside coagulation monitors.
    Hézard N; Metz D; Potron G; Nazeyrollas P; Maes D; Droulle C; Mulpas MC; Elaerts J; Nguyen P
    Thromb Haemost; 1998 Nov; 80(5):865-6. PubMed ID: 9843190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.